Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Opiant Pharmaceuticals
Santa Monica, California, United Statesopiant.com ↗
- Ownership
- Public · OPNT
- Employees
- ~38
- Development stage
- Other
01
Overview
Opiant developed NARCAN® nasal spray—an FDA-approved treatment to reverse opioid overdoses—and advanced a pipeline focused on addiction and overdose. Its lead asset at acquisition was OPNT003, a late-stage investigational opioid overdose treatment targeting synthetic opioids like fentanyl. Other assets included a Phase II program in alcohol use disorder and a preclinical CB1 antagonist program for acute cannabinoid overdose[2][5].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule (e.g., naloxone hydrochloride)Peptides (for some investigational programs)Nasal spray drug delivery (Device/Drug combination)
- Industry
- Biotech
02
Partnerships
National Institute on Drug Abuse (NIDA)Biological Advanced Research and Development Authority (BARDA)Adapt Pharma/Emergent BioSolutions via licensing of NARCAN[2][6]
Beyond the preview
Go deeper on Opiant Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Opiant Pharmaceuticals.